dei |
Entity Common Stock, Shares Outstanding |
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. |
View
|
dei |
Entity Public Float |
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. |
View
|
us-gaap |
Additional Paid in Capital |
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. |
View
|
us-gaap |
Due to Related Parties, Current |
Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Earnings Per Share, Basic and Diluted |
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. |
View
|
us-gaap |
Net Cash Provided by (Used in) Operating Activities |
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. |
View
|
us-gaap |
Selling, General and Administrative Expense |
The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
View
|
us-gaap |
Stock Issued During Period, Value, New Issues |
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
View
|
us-gaap |
Deferred Tax Assets, Valuation Allowance |
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. |
View
|
us-gaap |
Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
Cumulative net losses reported during the development stage. |
View
|
us-gaap |
Deferred Tax Assets, Net of Valuation Allowance |
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. |
View
|
us-gaap |
Accounts Payable (Deprecated 2009-01-31) |
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date). |
View
|
us-gaap |
Accounts Payable, Current |
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
View
|
us-gaap |
Additional Paid in Capital, Common Stock |
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
View
|
us-gaap |
Advertising Revenue Cost (Deprecated 2018-01-31) |
Costs incurred and are directly related to generating advertising revenues. |
View
|
us-gaap |
Share-based Payment Arrangement, Expense |
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. |
View
|
us-gaap |
Assets |
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Assets, Current |
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. |
View
|
us-gaap |
Cash |
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Cash and Cash Equivalents, at Carrying Value |
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Cash and Cash Equivalents, Period Increase (Decrease) |
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. |
View
|
us-gaap |
Cash Equivalents, at Carrying Value |
Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
View
|
us-gaap |
Common Stock, Par or Stated Value Per Share |
Face amount or stated value per share of common stock. |
View
|
us-gaap |
Common Stock, Shares Authorized |
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Common Stock, Shares, Issued |
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. |
View
|
us-gaap |
Common Stock, Shares, Outstanding |
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. |
View
|
us-gaap |
Common Stock, Value, Issued |
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
View
|
us-gaap |
Deferred Tax Assets, Gross |
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. |
View
|
us-gaap |
Due to Related Parties, Noncurrent |
Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Percent |
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
Percentage of domestic federal statutory tax rate applicable to pretax income (loss). |
View
|
us-gaap |
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent |
Amount after tax of income (loss) from continuing operations attributable to the parent. |
View
|
us-gaap |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest |
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
View
|
us-gaap |
Income (Loss) from Continuing Operations, Per Basic and Diluted Share |
The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. |
View
|
us-gaap |
Income Tax Expense (Benefit) |
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
View
|
us-gaap |
Income Taxes Paid |
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount |
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount |
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. |
View
|
us-gaap |
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount |
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). |
View
|
us-gaap |
Increase (Decrease) in Accounts Payable |
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
View
|
us-gaap |
Increase (Decrease) in Accrued Liabilities |
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
View
|
us-gaap |
Interest Paid, Including Capitalized Interest, Operating and Investing Activities |
Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. |
View
|
us-gaap |
Liabilities |
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. |
View
|
us-gaap |
Liabilities and Equity |
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
View
|
us-gaap |
Liabilities, Current |
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
View
|
us-gaap |
Notes Payable, Noncurrent |
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
View
|
us-gaap |
Net Cash Provided by (Used in) Financing Activities |
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
View
|
us-gaap |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period |
Number of share options (or share units) exercised during the current period. |
View
|
us-gaap |
Net Income (Loss) Attributable to Parent |
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
View
|
us-gaap |
Notes Payable, Current |
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
View
|
us-gaap |
Operating Expenses |
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
View
|
us-gaap |
Operating Loss Carryforwards |
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. |
View
|
us-gaap |
Other Notes Payable, Current |
Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer. |
View
|
us-gaap |
Preferred Stock, Par or Stated Value Per Share |
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. |
View
|
us-gaap |
Preferred Stock, Shares Authorized |
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. |
View
|
us-gaap |
Preferred Stock, Shares Issued |
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. |
View
|
us-gaap |
Preferred Stock, Shares Outstanding |
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. |
View
|
us-gaap |
Proceeds from Issuance of Common Stock |
The cash inflow from the additional capital contribution to the entity. |
View
|
us-gaap |
Proceeds from Related Party Debt |
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
View
|
us-gaap |
Professional Fees |
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. |
View
|
us-gaap |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest |
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
View
|
us-gaap |
Related Party Transaction, Amounts of Transaction |
Amount of transactions with related party during the financial reporting period. |
View
|
us-gaap |
Related Party Transaction, Due from (to) Related Party |
Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. |
View
|
us-gaap |
Retained Earnings (Accumulated Deficit) |
The cumulative amount of the reporting entity's undistributed earnings or deficit. |
View
|
us-gaap |
Revenues |
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
View
|
us-gaap |
Sale of Stock, Price Per Share |
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. |
View
|
us-gaap |
Shares, Issued |
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. |
View
|
us-gaap |
Stockholders' Equity Attributable to Parent |
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. |
View
|
us-gaap |
Stock Issued During Period, Shares, New Issues |
Number of new stock issued during the period. |
View
|
us-gaap |
Stock Issued During Period, Shares, Reverse Stock Splits |
Reduction in the number of shares during the period as a result of a reverse stock split. |
View
|
us-gaap |
Stock Issued During Period, Value, Stock Options Exercised |
Value of stock issued as a result of the exercise of stock options. |
View
|
us-gaap |
Valuation Allowance, Amount (Deprecated 2013-01-31) |
The amount of the valuation allowance recorded as of the balance sheet date pertaining to the specified deferred tax asset for which an assessment was made that it is more likely than not that all or a portion of such deferred tax asset will not be realized through related deductions on future tax returns. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Basic and Diluted |
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Basic |
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
View
|
us-gaap |
Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) |
The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. |
View
|